RBC
CLB icon

Ronald Blue & Co’s Core Laboratories CLB Stock Holding History

Ronald Blue & Co’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-2,144
Closed -$214K – 211
2015
Q3 		$214K Sell
2,144
-421
-16% -$45.8K 0.01% 266
2015
Q2 		$293K Buy
2,565
+2
+0.1% +$243 0.01% 256
2015
Q1 		$268K Buy
2,563
+549
+27% +$58.5K 0.01% 278
2014
Q4 		$242K Sell
2,014
-532
-21% -$69.9K 0.01% 292
2014
Q3 		$373K Buy
2,546
+220
+9% +$34K 0.02% 196
2014
Q2 		$389K Buy
2,326
+359
+18% +$63.9K 0.02% 194
2014
Q1 		$390K Buy
1,967
+424
+27% +$80K 0.03% 178
2013
Q4 		$295K Buy
+1,543
New +$287K 0.02% 215

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
WP
Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return
RFC
Russell Frank Company Seattle, Washington $56.9B AUM 2.13% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Ronald Blue & Co's CLB Position: Q4 2015 in Review

Ronald Blue & Co sold out of Core Laboratories (CLB) in Q4 2015, closing a stake of 2,144 shares — an estimated $214K sold.

Ronald Blue & Co first reported a position in CLB in Q4 2013 and held it in 8 quarters. The position peaked at $390K in Q1 2014. 371 funds tracked by Wall St. Rank hold CLB as of Q4 2015.

  • Ronald Blue & Co reported no remaining Core Laboratories position as of Q4 2015 after selling out during the quarter.
  • Ronald Blue & Co sold 2,144 Core Laboratories shares in Q4 2015, an estimated $214K.
  • Ronald Blue & Co first reported a position in Core Laboratories in Q4 2013 and held it in 8 quarters.
  • Ronald Blue & Co's Core Laboratories position peaked at $390K in Q1 2014.
  • 371 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2015.

Based on Ronald Blue & Co's 13F filing for Q4 2015, filed 11 Feb 2016.